216 related articles for article (PubMed ID: 24921215)
1. Current challenges and the management of chronic hepatitis C in mainland China.
Duan Z; Jia JD; Hou J; Lou L; Tobias H; Xu XY; Wei L; Zhuang H; Pan CQ
J Clin Gastroenterol; 2014 Sep; 48(8):679-86. PubMed ID: 24921215
[TBL] [Abstract][Full Text] [Related]
2. NIH Consensus Statement on Management of Hepatitis C: 2002.
NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
[TBL] [Abstract][Full Text] [Related]
3. A phase 3, open-label study of daclatasvir plus asunaprevir in Asian patients with chronic hepatitis C virus genotype 1b infection who are ineligible for or intolerant to interferon alfa therapies with or without ribavirin.
Wei L; Zhang M; Xu M; Chuang WL; Lu W; Xie W; Jia Z; Gong G; Li Y; Bae SH; Yang YF; Xie Q; Lin S; Chen X; Niu J; Jia J; Garimella T; Torbeyns A; McPhee F; Treitel M; Yin PD; Mo L
J Gastroenterol Hepatol; 2016 Nov; 31(11):1860-1867. PubMed ID: 27003037
[TBL] [Abstract][Full Text] [Related]
4. Daclatasvir for the Treatment of Chronic Hepatitis C: A Critique of the Clinical and Economic Evidence.
Llewellyn A; Faria R; Woods B; Simmonds M; Lomas J; Woolacott N; Griffin S
Pharmacoeconomics; 2016 Oct; 34(10):981-92. PubMed ID: 27278217
[TBL] [Abstract][Full Text] [Related]
5. Real life efficacy and safety of direct-acting antiviral therapy for treatment of patients infected with hepatitis C virus genotypes 1, 2 and 3 in northwest China.
Yang Y; Wu FP; Wang WJ; Shi JJ; Li YP; Zhang X; Dang SS
World J Gastroenterol; 2019 Nov; 25(44):6551-6560. PubMed ID: 31802834
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C Infection in the Elderly.
Saab S; Rheem J; Sundaram V
Dig Dis Sci; 2015 Nov; 60(11):3170-80. PubMed ID: 26008618
[TBL] [Abstract][Full Text] [Related]
7. Urgency to treat patients with chronic hepatitis C in Asia.
Kao JH; Ahn SH; Chien RN; Cho M; Chuang WL; Jeong SH; Liu CH; Paik SW
J Gastroenterol Hepatol; 2017 May; 32(5):966-974. PubMed ID: 28005275
[TBL] [Abstract][Full Text] [Related]
8. [Real-world study of paritaprevir/ritonavir-ombitasvir combined with dasabuvir for the treatment of chronic hepatitis C 1b genotype infection in China].
Jie YS; Yuan J; Zhang XH; Guan YJ; Zhao ZX; Chong YT; Tao L; Li JP; Lin CS
Zhonghua Gan Zang Bing Za Zhi; 2019 Feb; 27(2):123-127. PubMed ID: 30818917
[No Abstract] [Full Text] [Related]
9. Treatment of hepatitis C: a systematic review.
Kohli A; Shaffer A; Sherman A; Kottilil S
JAMA; 2014 Aug; 312(6):631-40. PubMed ID: 25117132
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C-A clinical review.
Wang LS; D'Souza LS; Jacobson IM
J Med Virol; 2016 Nov; 88(11):1844-55. PubMed ID: 27097298
[TBL] [Abstract][Full Text] [Related]
11. Direct-acting antivirals for chronic hepatitis C.
Jakobsen JC; Nielsen EE; Feinberg J; Katakam KK; Fobian K; Hauser G; Poropat G; Djurisic S; Weiss KH; Bjelakovic M; Bjelakovic G; Klingenberg SL; Liu JP; Nikolova D; Koretz RL; Gluud C
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD012143. PubMed ID: 28922704
[TBL] [Abstract][Full Text] [Related]
12. [A phase II, single-arm, open-label, multicenter clinical study to evaluate the efficacy and safety of sofosbuvir combined with ribavirin in patients with genotype 2 chronic hepatitis C virus infection].
Gao YH; Li GM; Jin QL; Zhao YR; Jia ZS; Mao XR; Yang YF; Shang J; Wang GC; Xie W; Wu SM; Zhang MX; Hou JL; Li DL; Nan YM; Guan YJ; Zhu CX; Yuan YZ; Wei L
Zhonghua Gan Zang Bing Za Zhi; 2019 May; 27(5):352-357. PubMed ID: 31177659
[No Abstract] [Full Text] [Related]
13. Hepatitis C Virus: Current and Evolving Treatments for Genotype 4.
Asselah T; Bourlière M
Gastroenterol Clin North Am; 2015 Dec; 44(4):859-70. PubMed ID: 26600224
[TBL] [Abstract][Full Text] [Related]
14. Distribution and clinical correlates of viral and host genotypes in Chinese patients with chronic hepatitis C virus infection.
Rao H; Wei L; Lopez-Talavera JC; Shang J; Chen H; Li J; Xie Q; Gao Z; Wang L; Wei J; Jiang J; Sun Y; Yang R; Li H; Zhang H; Gong Z; Zhang L; Zhao L; Dou X; Niu J; You H; Chen Z; Ning Q; Gong G; Wu S; Ji W; Mao Q; Tang H; Li S; Wei S; Sun J; Jiang J; Lu L; Jia J; Zhuang H
J Gastroenterol Hepatol; 2014 Mar; 29(3):545-53. PubMed ID: 24090188
[TBL] [Abstract][Full Text] [Related]
15. Heading Toward the Elimination of Hepatitis C Virus.
Kershenobich D; Torre-Delgadillo A; Aguilar-Valenzuela LM
Rev Invest Clin; 2018; 70(1):29-31. PubMed ID: 29513300
[TBL] [Abstract][Full Text] [Related]
16. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2/3 trial.
Andrieux-Meyer I; Tan SS; Thanprasertsuk S; Salvadori N; Menétrey C; Simon F; Cressey TR; Said HRHM; Hassan MRA; Omar H; Tee HP; Chan WK; Kumar S; Thongsawat S; Thetket K; Avihingsanon A; Khemnark S; Yerly S; Ngo-Giang-Huong N; Siva S; Swanson A; Goyal V; Bompart F; Pécoul B; Murad S
Lancet Gastroenterol Hepatol; 2021 Jun; 6(6):448-458. PubMed ID: 33865507
[TBL] [Abstract][Full Text] [Related]
18. Direct-acting antiviral therapy for hepatitis C virus infection in the kidney transplant recipient.
Chute DF; Chung RT; Sise ME
Kidney Int; 2018 Mar; 93(3):560-567. PubMed ID: 29325996
[TBL] [Abstract][Full Text] [Related]
19. Experience of a Portuguese Center: Effectiveness of Direct-Acting Antiviral Therapy for Hepatitis C.
Falcão F; Lopes C; Viegas E; Perez R; Aldir I; Farinha H; Carvalho A; Mirco A; Marques S; Bana E Costa T; Miranda AC; Lebre L; Peixe P; Chagas C; Mansinho K; Correia JM
Acta Med Port; 2019 Mar; 32(3):189-194. PubMed ID: 30946789
[TBL] [Abstract][Full Text] [Related]
20. Current Treatment Options in Patients with Hepatitis C Virus Genotype 6.
Nguyen NH; Nguyen MH
Gastroenterol Clin North Am; 2015 Dec; 44(4):871-81. PubMed ID: 26600225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]